21563 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a NS, NS, NS, N chelating group Metallocenes, i.e. complexes based on a radioactive metal complexed by two cyclopentadienyl anions
CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
#2CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
#3PSMA-targeted radiopharmaceutical for diagnosing and treating prostate cancer
#4METHOD FOR TREATING CANCER BASED ON METALLOFULLERENE MONOCRYSTALLINE NANOPARTICLES THAT SPECIFICALLY DISRUPT TUMOR BLOOD VESSELS
#5IN VIVO STABLE HG-197(M) COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF IN NUCLEAR MEDICAL DIAGNOSTICS AND ENDORADIONUCLIDE THERAPY (THERANOSTICS)
#6CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
#7CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING
#8A METHOD FOR TREATING CANCER BASED ON METALLOFULLERENE MONOCRYSTALLINE NANOPARTICLES THAT SPECIFICALLY DISRUPT TUMOR BLOOD VESSELS
#9Metallocene compounds and labeled molecules comprising the same for in vivo imaging
#10Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging
#11Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease
#12Ghrelin analogues
#13PENDANT FATTY ACID IMAGING AGENTS
#14Tumor imaging compounds
#15Pendant fatty acid imaging agents
#16Tumor imaging compounds